Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record metadata now shows revision v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:49:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a publication reference by Kuemmel et al. about KEYNOTE-522 in Ann Surg Oncol to the Publications section.
    Difference
    0.0%
    Check dated 2026-03-04T13:31:47.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding status notice and the earlier Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-11T03:06:48.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new global notice about government funding and operating status has been added to the top of the page, and the version number has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T01:30:21.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-27T23:51:17.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    A new publication citation was added to the Publications section: Pembrolizumab for Early-Stage Triple-Negative Breast Cancer—KEYNOTE-522 Japan Subgroup Analysis (Cancer Sci. 2026 Jan 14).
    Difference
    0.0%
    Check dated 2026-01-20T21:29:23.000Z thumbnail image

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.